Sarah Picardo

801 total citations
16 papers, 334 citations indexed

About

Sarah Picardo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Sarah Picardo has authored 16 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Sarah Picardo's work include Esophageal Cancer Research and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Sarah Picardo is often cited by papers focused on Esophageal Cancer Research and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Sarah Picardo collaborates with scholars based in Ireland, Canada and United States. Sarah Picardo's co-authors include Aaron R. Hansen, Bryan Coburn, John V. Reynolds, Jacintha O’Sullivan, Stephen G. Maher, Deirdre O’Riordan, Michael K. Dalton, Bernard Silke, Sanjay H. Chotirmall and Naoimh J. O’Farrell and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sarah Picardo

16 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Picardo Ireland 9 121 114 112 71 53 16 334
Kathryn M. Ziegler United States 9 76 0.6× 166 1.5× 127 1.1× 92 1.3× 60 1.1× 21 322
A. S. Miller United Kingdom 13 92 0.8× 240 2.1× 211 1.9× 57 0.8× 69 1.3× 23 480
Simcha Weissman United States 10 47 0.4× 193 1.7× 151 1.3× 114 1.6× 77 1.5× 66 384
Ana López Spain 12 91 0.8× 65 0.6× 183 1.6× 94 1.3× 93 1.8× 35 442
Yoon Jung Oh South Korea 14 206 1.7× 75 0.7× 81 0.7× 204 2.9× 42 0.8× 29 514
Fernando Fonseca Brazil 11 57 0.5× 94 0.8× 28 0.3× 67 0.9× 33 0.6× 26 316
Saad Saleem United States 8 52 0.4× 202 1.8× 74 0.7× 140 2.0× 39 0.7× 48 356
Xianzhen Peng China 11 98 0.8× 65 0.6× 52 0.5× 58 0.8× 94 1.8× 16 341
Dominic Slade United Kingdom 9 110 0.9× 133 1.2× 48 0.4× 53 0.7× 37 0.7× 26 323
Thyra Löwenmark Sweden 8 96 0.8× 227 2.0× 215 1.9× 46 0.6× 29 0.5× 10 413

Countries citing papers authored by Sarah Picardo

Since Specialization
Citations

This map shows the geographic impact of Sarah Picardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Picardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Picardo more than expected).

Fields of papers citing papers by Sarah Picardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Picardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Picardo. The network helps show where Sarah Picardo may publish in the future.

Co-authorship network of co-authors of Sarah Picardo

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Picardo. A scholar is included among the top collaborators of Sarah Picardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Picardo. Sarah Picardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Iafolla, Marco, Sarah Picardo, Kyaw Aung, & Aaron R. Hansen. (2020). Systematic Review and STARD Scoring of Renal Cell Carcinoma Circulating Diagnostic Biomarker Manuscripts. JNCI Cancer Spectrum. 4(5). pkaa050–pkaa050. 2 indexed citations
2.
O’Kane, Grainne M., Sarah Picardo, Amy Zhang, et al.. (2020). Homologous recombination deficiency (HRD) scoring in pancreatic ductal adenocarcinoma (PDAC) and response to chemotherapy.. Journal of Clinical Oncology. 38(4_suppl). 741–741. 3 indexed citations
3.
Picardo, Sarah, Marco Iafolla, Srikala S. Sridhar, et al.. (2020). Prognostic factors that affect survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223.. Journal of Clinical Oncology. 38(6_suppl). 225–225. 2 indexed citations
4.
O’Kane, Grainne M., Gun Ho Jang, Amy Zhang, et al.. (2020). Outcomes and Immunogenicity of pancreatic cancer stratified by the HRDetect score.. Journal of Clinical Oncology. 38(15_suppl). 4630–4630. 3 indexed citations
5.
Iafolla, Marco, Sarah Picardo, Kyaw Aung, & Aaron R. Hansen. (2019). Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts. PLoS ONE. 14(10). e0222359–e0222359. 8 indexed citations
6.
Picardo, Sarah, Bryan Coburn, & Aaron R. Hansen. (2019). The microbiome and cancer for clinicians. Critical Reviews in Oncology/Hematology. 141. 1–12. 97 indexed citations
7.
O’Farrell, Naoimh J., J.J. Phelan, Brendan Doyle, et al.. (2019). Differential Expression Profiles of Oxidative Stress Levels, 8-oxo-dG and 4-HNE, in Barrett’s Esophagus Compared to Esophageal Adenocarcinoma. International Journal of Molecular Sciences. 20(18). 4449–4449. 20 indexed citations
8.
Picardo, Sarah, et al.. (2019). Structure and Optimization of Checkpoint Inhibitors. Cancers. 12(1). 38–38. 41 indexed citations
9.
Ahmed, Yasar, Sarah Picardo, James M. Crotty, et al.. (2018). Unusual Sites of High-Grade Neuroendocrine Carcinomas: A Case Series and Review of the Literature. American Journal of Case Reports. 19. 710–723. 10 indexed citations
10.
Picardo, Sarah, Jing Sui, Megan Greally, et al.. (2017). Oncotype DX score, menopausal status and body mass index. Annals of Oncology. 28. v59–v59. 4 indexed citations
11.
Ahmed, Yasar, et al.. (2017). Real-world experience with abiraterone in metastatic castration-resistant prostate cancer. SHILAP Revista de lepidopterología. 3(4). 133–133. 3 indexed citations
12.
O’Farrell, Naoimh J., Sarah Picardo, Niamh Lynam‐Lennon, et al.. (2016). Changes in mitochondrial stability during the progression of the Barrett’s esophagus disease sequence. BMC Cancer. 16(1). 497–497. 12 indexed citations
13.
Picardo, Sarah, Min Yuen Teo, Syed Yaseen Naqvi, et al.. (2016). Correlation between platelet/lymphocyte ratio, neutrophil/lymphocyte ratio and response to neoadjuvant chemoradiation therapy in rectal cancer.. Journal of Clinical Oncology. 34(15_suppl). e15140–e15140. 3 indexed citations
14.
Picardo, Sarah, Dermot O’Toole, Narayanasamy Ravi, et al.. (2014). A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia. Diseases of the Esophagus. 28(2). 121–126. 28 indexed citations
15.
Chotirmall, Sanjay H., et al.. (2014). Disabling disease codes predict worse outcomes for acute medical admissions. Internal Medicine Journal. 44(6). 546–553. 46 indexed citations
16.
Picardo, Sarah, Stephen G. Maher, Jacintha O’Sullivan, & John V. Reynolds. (2012). Barretts to Oesophageal Cancer Sequence: A Model of Inflammatory-Driven Upper Gastrointestinal Cancer. Digestive Surgery. 29(3). 251–260. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026